Related references
Note: Only part of the references are listed.Potent antitumor effect of TRAIL mediated by a novel adeno-associated viral vector targeting to telomerase activity for human hepatocellular carcinoma
Yigang Wang et al.
JOURNAL OF GENE MEDICINE (2008)
Engineering and selection of shuffled AAV genomes: A new strategy for producing targeted biological nanoparticles
Wuping Li et al.
MOLECULAR THERAPY (2008)
Engineering adeno-associated virus 2 vectors for targeted gene delivery to atherosclerotic lesions
K. White et al.
GENE THERAPY (2008)
Vectors selected from adeno-associated viral display peptide libraries for leukemia cell-targeted cytotoxic gene therapy
Stefan Michelfelder et al.
EXPERIMENTAL HEMATOLOGY (2007)
TERT promoter-driven adenovirus vector for cancer gene therapy via systemic injection
Xinglei Yao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
The state of the art of adeno-associated virus-based vectors in gene therapy
Renata dos Santos Coura et al.
VIROLOGY JOURNAL (2007)
Inhibition of corneal neovascularization with endostatin delivered by adeno-associated viral (AAV) vector in a mouse corneal injury model
Li-Ju Lai et al.
JOURNAL OF BIOMEDICAL SCIENCE (2007)
High-efficiency promoter-dependent transduction by adeno-associated virus type 6 vectors in mouse lung
Christine L. Halbert et al.
HUMAN GENE THERAPY (2007)
Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display
Seung-Min Lee et al.
MOLECULAR CANCER RESEARCH (2007)
Isolation of targeted AAV2 vectors from novel virus display libraries
Daniel A. Waterkamp et al.
JOURNAL OF GENE MEDICINE (2006)
Heparan sulfate proteoglycan binding properties of adeno-associated virus retargeting mutants and consequences for their in vivo tropism
Luca Perabo et al.
JOURNAL OF VIROLOGY (2006)
Lymphatic zip codes in premalignant lesions and tumors
Lianglin Zhang et al.
CANCER RESEARCH (2006)
Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer
Olga Vasiljeva et al.
CANCER RESEARCH (2006)
Synchronous selection of homing peptides for multiple tissues by in vivo phage display
Mikhail G. Kolonin et al.
FASEB JOURNAL (2006)
A hybrid vector for ligand-directed tumor targeting and molecular imaging
A Hajitou et al.
CELL (2006)
Vascular bed-targeted in vivo gene delivery using tropism-modified adeno-associated viruses
LM Work et al.
MOLECULAR THERAPY (2006)
Insertional mutagenesis at positions 520 and 584 of adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors with eliminated heparin binding ability and introduced novel tropism
XQ Shi et al.
HUMAN GENE THERAPY (2006)
Directed evolution of adeno-associated virus yields enhanced gene delivery vectors
N Maheshri et al.
NATURE BIOTECHNOLOGY (2006)
Adeno-associated virus serotypes: Vector toolkit for human gene therapy
Zhijian Wu et al.
MOLECULAR THERAPY (2006)
Quantitative real-time PCR for titration of infectious recombinant AAV-2 particles
UP Rohr et al.
JOURNAL OF VIROLOGICAL METHODS (2005)
Adeno-associated virus vectors in clinical trials
BJ Carter
HUMAN GENE THERAPY (2005)
Targeted gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectors
SJ White et al.
CIRCULATION (2004)
Reversal of obesity by targeted ablation of adipose tissue
MG Kolonin et al.
NATURE MEDICINE (2004)
Immune responses to gene therapy vectors: influence on vector function and effector mechanisms
N Bessis et al.
GENE THERAPY (2004)
Identification of a heparin-binding motif on adeno-associated virus type 2 capsids
A Kern et al.
JOURNAL OF VIROLOGY (2003)
Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors
OJ Müller et al.
NATURE BIOTECHNOLOGY (2003)
In vitro selection of viral vectors with modified tropism:: The adeno-associated virus display
L Perabo et al.
MOLECULAR THERAPY (2003)
RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism
WF Shi et al.
MOLECULAR THERAPY (2003)
Ligand-directed targeting of genes to the site of disease
Thomas J. Wickham
NATURE MEDICINE (2003)
Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases
EY Lin et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis
JA Joyce et al.
CANCER CELL (2003)
Characterization of Herpes Simplex Virus type 1 thymidine kinase mutants engineered for improved ganciclovir or acyclovir activity
MS Kokoris et al.
PROTEIN SCIENCE (2002)
Fast and reliable titration of recombinant adeno-associated virus type-2 using quantitative real-time PCR
UP Rohr et al.
JOURNAL OF VIROLOGICAL METHODS (2002)
Teratogenicity induced by targeting a placental immunoglobulin transporter
MG Kolonin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo
K Porkka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Molecular specialization of breast vasculature: A breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature
M Essler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Targeting the prostate for destruction through a vascular address
W Arap et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Steps toward mapping the human vasculature by phage display
W Arap et al.
NATURE MEDICINE (2002)
Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids
M Grifman et al.
MOLECULAR THERAPY (2001)
Share Paper
